DOD Ovarian Cancer Translational Research Partnership

The summary for the DOD Ovarian Cancer Translational Research Partnership grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DOD Ovarian Cancer Translational Research Partnership: The OCRP Translational Research Partnership Award was first offered in FY07 to support partnerships between clinicians and laboratory scientists to conduct translational research in ovarian cancer. During this time, 22 proposals were received for the Translational Research Partnership Award, and 5 were recommended for funding. The key initiative of the Translational Research Partnership Award is to encourage partnerships between clinicians and laboratory scientists that accelerate the movement of promising ideas in ovarian cancer into clinical applications. This award supports the development of translational research collaborations between two independent investigators to address a central problem or question in ovarian cancer in a manner that would be less readily achievable through separate efforts. One partner in the collaboration must be a laboratory scientist and the other must be a clinician, and it should be clear that both have had equal intellectual input into the design of the research project. At least one member of the partnership must have experience either in ovarian cancer research or ovarian cancer patient care. Historically Black College and Universities/Minority Institutions are encouraged to apply. A proposed project in which the clinical partner merely supplies tissue samples or access to patients will not meet the intent of this mechanism.Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or a clinicians first hand knowledge of patients and anecdotal data. While the ultimate goal of translational research is to move an observation forward into the clinical application, members of the partnership should view translational research as a two-way continuum between bench and bedside. Developing the research plan must involve a reciprocal flow of ideas and information within the partnership. Developmental pathways for translational research that may be useful for designing translational research studies for support under this mechanism may be found at (http://www.cancer.gov/aboutnci/trwg/Pathways-to-Clinical-Goals). These pathways are comprehensive and span the entire translational research continuum from discovery of a target to clinical trials. Please be aware that the Translational Research Partnership Award does not support clinical trials, but may support correlative studies that are associated with an existing clinical trial and projects that develop clinical endpoints for clinical trials. Research projects may also include preclinical studies in animal models and human subjects and human anatomical substances.This award is intended to support both new and established scientists across a broad spectrum of disciplines in research projects that are likely to make a major impact on ovarian cancer. NEW FOR FY08 - The Translational Research Partnership award accepts proposals from all areas of research, but encourages research from these Areas of Encouragement:. Identification and characterization of early changes associated with ovarian cancer.. Identification and characterization of ovarian cancer stem cells.. The contribution of the stroma to the tumor microenvironment in ovarian cancer.Proposals addressing one of these three Areas of Encouragement will be given primary consideration.This award mechanism is not intended to support the study of new combinations of conventional ovarian cancer therapies. The use of existing resources is encouraged, including libraries of compounds or probes, tissue repositories such as those managed by the Gynecologic Oncology Group, and other existing sets of tissue, blood, or images. Important aspects of the Translational Research Partnership Award are as follows:1. Partnership: The success of the project depends on the unique skills and contributions of each partner. . Optional Non-traditional Partnership (NEW FOR FY08): This award encourages a partnership between an academic institution/government agency and a biotechnology/pharmaceutical company, or between an academic institution/government agency and a foundation, or between a biotechnology/pharmaceutical company and a foundation. The intent of this optional non-traditional partnership is to leverage resources in the ovarian cancer research community. It is expected that in addition to providing intellectual input, the optional non-traditional partnership will contribute research resources (e.g., supplies, reagents, equipment, personnel) and/or financial resources.2. Impact: The proposed research should have a significant impact on the concepts or methods that are likely to accelerate the movement of promising ideas in ovarian cancer into clinical applications.3. Preliminary Data: Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be in ovarian cancer.
Federal Grant Title: DOD Ovarian Cancer Translational Research Partnership
Federal Agency Name: Dept of the Army USAMRAA
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: W81XWH-08-OCRP-TRP
Type of Funding: Cooperative Agreement Grant
CFDA Numbers: 12.420
CFDA Descriptions: Military Medical Research and Development
Current Application Deadline: No deadline provided
Original Application Deadline: Jul 02, 2008
Posted Date: Feb 07, 2008
Creation Date: Feb 13, 2008
Archive Date: Aug 01, 2008
Total Program Funding: $2,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 2
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
CDMRP Helpdesk
Phone 301-619-7079 [email protected] CDMRP Helpdesk
Similar Government Grants
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research a...
DoD Kidney Cancer, Clinical Consortium Award
DOD Toxic Exposures, Translational Research Award
DOD Toxic Exposures, Investigator-Initiated Research Award
DOD Toxic Exposures, Clinical Trial Award
FY2006 Deployed War Fighter Protection Research Program
Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Dept of the Army USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research a...
DoD Kidney Cancer, Clinical Consortium Award
DOD Toxic Exposures, Translational Research Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com